Shareholdings
| Concept |
As at 2025-03-31 |
2024-04-01 to 2025-03-31 |
|---|---|---|
| Shareholdings | ||
| Reporting company | ||
| Investment shares held for purposes other than pure investment | ||
| Shares not listed | ||
| Number of issues |
5
xbrli:pure
|
— |
| Carrying amount |
1,148,000,000
JPY
|
— |
| Number of issues whose number of shares increased | — |
1
xbrli:pure
|
| Total acquisition cost for increased shares | — |
504,000,000
JPY
|
| Reason for increase in number of shares | — |
最先端ＤＮＡ合成技術及びバイオファウンドリサービスを活用し、「バイオものづくり」に関する技術開発と事業化を推進するため。
|
| Number of issues whose number of shares decreased | — |
xbrli:pure
|
| Total sale amount for decreased shares | — |
JPY
|
| Shares other than those not listed | ||
| Number of issues |
11
xbrli:pure
|
— |
| Carrying amount |
17,321,000,000
JPY
|
— |
| Number of issues whose number of shares increased | — |
xbrli:pure
|
| Total acquisition cost for increased shares | — |
JPY
|
| Reason for increase in number of shares | — |
|
| Number of issues whose number of shares decreased | — |
9
xbrli:pure
|
| Total sale amount for decreased shares | — |
6,674,000,000
JPY
|